Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations.
Cancer Chemother Pharmacol
; 91(3): 239-246, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36884068
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein-Tyrosine Kinases
/
Neoplasms
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: